Kavach 9 Pharma & Research Private Limited - Company Profile

It is a pharma private limited company based in Ahemdabad, Gujarat, India, established in 2014.
2014 Ahemdabad, Gujarat, India Active
Last Updated:
Access Report
About Kavach 9 Pharma & Research Private Limited

Kavach 9 Pharma & Research Private Limited, a active private limited company, was established on 13 October 2014 in Ahemdabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232GJ2014PTC081027. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.10 M and a paid-up capital of ₹1.03 M.

It upholds a compliant status. Employing 22 professional, Its leadership includes Ronakkumar Bhatt (Director), Charmi Rajeshkumar Radadia (Director), Ankita Sunil Patel (Director). Past directors included Siddharth Unnativardhan, Ronakkumar Bhatt, Gayatri Bhavesh Patel. It holds ₹8.19 M open charges and ₹3.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S.F.- 216, Sigma Arcade, Kailas Bunglow, O.N.G.C.Rd, Sabarmati, Chandkheda,, Ahemdabad, Gujarat, 382424.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232GJ2014PTC081027

  • Registration Number

    081027

  • Incorporation Date

    13 October 2014

  • Authorized Capital

    ₹1.10 M

  • Paid-Up Capital

    ₹1.03 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.10 M
  • Paid Up Capital ₹ 1.03 M
  • Company Age 11 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.19 M
  • Satisfied Charges ₹ 3.00 M
  • Revenue Growth **** 9.21%
  • Profit Growth **** -2411.59%
  • Ebitda **** -577.08%
  • Net Worth -106.76%
  • Total Assets **** 2.73%
Company report

Kavach 9 Pharma & Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kavach 9 Pharma & Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kavach 9 Pharma & Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Ronakkumar Bhatt Director 01 Sep 2016 Current
Charmi Rajeshkumar Radadia Director 13 Oct 2014 Current
Ankita Sunil Patel Director 13 Oct 2014 Current
Babubhai Vashrambhai Patel Director 01 Mar 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Director 03 Jan 2025 Past
Pramod Abcsdd Director 30 Oct 2017 Past
Pramod Abcsdd Managing Director 24 Nov 2016 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kavach 9 Pharma & Research.

Kavach 9 Pharma & Research Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.21% increase. The company also saw a substantial fall in profitability, with a 2411.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 106.76%.

Kavach 9 Pharma & Research revenue growth over time
Kavach 9 Pharma & Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.21%
*******
*******
*******
*******
Revenue from Operations
*******
 9.51%
*******
*******
*******
*******
Total Assets
*******
 2.73%
*******
*******
*******
*******
Profit or Loss
*******
 -2411.59%
*******
*******
*******
*******
Net Worth
*******
 -106.76%
*******
*******
*******
*******
EBITDA
*******
 -577.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kavach 9 Pharma & Research?

Unlock access to Kavach 9 Pharma & Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,188,000.00

Satisfied Charges

₹3,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.82 Cr
Latest Charge Details
Date Lender Amount Status
24 Sep 2020 Others ₹0.69 M Open
21 Oct 2019 Others ₹7.50 M Open
25 May 2017 Bank Of India ₹3.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Kavach 9 Pharma & Research?

Kavach 9 Pharma & Research has a workforce of 22 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kavach 9 Pharma & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kavach 9 Pharma & Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kavach 9 Pharma & Research
Recent Activity within the Organization
  • Annual General Meeting

    Kavach 9 Pharma & Research Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Kavach 9 Pharma & Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    The activity Babubhai Vashrambhai Patel was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 1 year 15 days . was completed.

  • Charges

    Progress on A charge with Others of Rs. 7.50 M registered on 21 Oct 2019 with Charge ID 100300946 was modified on 11 Nov 2024. was documented.

  • Charges

    Progress on A charge with Others of Rs. 0.69 M registered on 24 Sep 2020 with Charge ID 100378684 was modified on 30 Sep 2020. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.69 M with Charge ID 100378684 was registered on 24 Sep 2020. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kavach 9 Pharma & Research Private Limited?

The CIN of Kavach 9 Pharma & Research Private Limited is U24232GJ2014PTC081027.

Where is Kavach 9 Pharma & Research Private Limited headquartered?

Kavach 9 Pharma & Research Private Limited is headquartered at S.F.- 216, Sigma Arcade, Kailas Bunglow, O.N.G.C.Rd, Sabarmati, Chandkheda,, Ahemdabad, Gujarat, 382424.

When was Kavach 9 Pharma & Research Private Limited incorporated?

Kavach 9 Pharma & Research Private Limited was incorporated on 13 October 2014.

Who are the current directors of Kavach 9 Pharma & Research Private Limited?

The current directors of Kavach 9 Pharma & Research Private Limited are

What is the primary industry of Kavach 9 Pharma & Research Private Limited?

The primary industry of Kavach 9 Pharma & Research Private Limited is Trade.

Is Kavach 9 Pharma & Research Private Limited a listed company?

Kavach 9 Pharma & Research Private Limited is unlisted.

What is the capital structure of Kavach 9 Pharma & Research Private Limited?

The authorized capital of Kavach 9 Pharma & Research Private Limited is ₹1.10 M, and the paid-up capital is ₹1.03 M.

What is the compliance status of Kavach 9 Pharma & Research Private Limited?

The compliance status of Kavach 9 Pharma & Research Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available